Biogen sets $55K annual price tag on new MS drug

There are 1 comment on the Business Journal story from Apr 1, 2013, titled Biogen sets $55K annual price tag on new MS drug. In it, Business Journal reports that:

Two days after the U.S. approval of a new multiple sclerosis drug at least one analyst expects to eventually hit $6 billion in annual sales, Biogen Idec announced a $54,900 annual price per patient for Tecfidera.

Join the discussion below, or Read more at Business Journal.

Chris

Boston, MA

#1 Apr 1, 2013
Robbery. 14 year patent protection should have kept this drug around 20k a year. All MS drugs are overpriced for their efficacy. How much will the upcoming drugs that may reverse the damage cost? 150k 200k a year? Where is the limit? I believe Pharma should be paid, but this is robbery. Just how much did it cost them not to have MS, Lupus, RA, etc? So glad the government is trying to protect me from guns and gay marriage instead of things I can't provide my own protection against.

Tell me when this thread is updated:

Subscribe Now Add to my Tracker

Add your comments below

Characters left: 4000

Please note by submitting this form you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.

Biotech Discussions

Title Updated Last By Comments
News Students receive expert tips on a host of subjects (Jun '09) Tue Randy Bradford 2
News Bristol Palin says abstinence best path for teens (May '09) May 14 swedenforever 2,621
News Vaccine industry has suppressed and intimidated... May 5 VACCINES MAIM KILL 1
News Oyez! Town Crier at Royal Baby Birth Captures A... May 4 Anita Bryant s Jihad 1
News Some beards are crappy because they are May 3 geri 1
News A3 adenosine receptor can activate 'off signals... Apr 25 bobb 1
News Bashful? Buy the little blue pill online (May '13) Apr '15 brianfarrel 13
More from around the web